Publications by authors named "Mike Trower"

Claim this Profile
E
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
James A Simon, Richard A Anderson, Elizabeth Ballantyne, James Bolognese, Cecilia Caetano, Mike Trower

Menopause· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women.
Steve Pawsey, Edouard Gregory Mills, Elizabeth Ballantyne, Kirsteen Donaldson, Mary Kerr, Mike Trower

J Clin Endocrinol Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To the Editor.
Steve Pawsey, James A Simon, Richard A Anderson, Waljit Dhillo, Hadine Joffe, Mike Trower

Menopause· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.
Mike Trower, Richard A Anderson, Elizabeth Ballantyne, Hadine Joffe, Mary Kerr

Menopause· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.
Bruno Vincenzi, Mike Trower, Ajay Duggal, Pamela Guglielmini, Peter Harris

BMJ Open· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis